Introduction by unknown
OPEN
Introduction
Fungal infections or mycoses are the great neglected diseases of medical
history.1 There are numerous histories of viral, bacterial and protozoan
infections, for all times and all places, but very few studies of those
caused by fungi. Why? It cannot be because of prevalence. Histori-
cal sources and contemporary epidemiological investigations show that
fungal infections were and are ubiquitous in human and animal popula-
tions. Everyone in Britain and the United States in the last half a century
would have heard of, if not suffered from, athlete’s foot or thrush. In the
ﬁrst half of the twentieth century, children feared the school nurse ﬁnd-
ing ringworm on their scalp and having to endure, not only the pains of
X-ray depilation or having their shaven head painted with gentian vio-
let, but also exclusion from school and the shame of being stigmatised
as ‘unclean’.2
It seems that medical historians have followed the agenda of the med-
ical profession in showing relatively little interest in conditions, such
as the majority of cases of mycoses, that do not lead to ‘illness’ as
such, but cause inﬂammation, irritation and discomfort. Medical history
remains dominated by studies of diseases that had, or continue to have,
a high proﬁle within medicine, or have attracted government interest
and investment because they cause signiﬁcant morbidity or mortality.
Yet, the majority experience of ill health was, and is, of self-limiting and
self-treated conditions, where sufferers did not, and do not, consult a
doctor and become ‘patients’. In their efforts to recover ‘the patient’s
view’, medical historians have ignored the minor illnesses, injuries and
infections that were, and remain, outside of the medical gaze.3
But medical historians have also largely ignored the ailments brought
on by medical advances, and here too the history of fungal infections
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can be instructive. The grand narrative of Western medicine in the
twentieth century was one of ‘progress’, evidenced by greater, scientiﬁ-
cally based knowledge of the aetiology and pathology of disease, more
accurate diagnostics, improved management of symptoms and pain,
more effective treatments, innovations in surgery, improved health care,
falling mortality rates and greater longevity.4 Those telling this story
recognised that progress was not unalloyed, yet amongst doctors such
was the step change in their effectiveness and efﬁciency that problems,
like the development of antibiotic resistance, were discounted or seen as
something that would be solved by further scientiﬁc and technological
advances.5 However, medical professionals soon realised that therapeu-
tic and technological advances often led to intractable problems; for
example, the practice of managing the adverse effects of one drug with
another could lead to patients taking more medicines to manage side
effects than for their primary illness. Such practices were criticised in
the 1960s, but for our narrative of fungal infections Ivan Illich’s book
Medical Nemesis, ﬁrst published in 1975, is most relevant.6 Illich made
iatrogenesis – doctor induced disease – central to his critique of mod-
ern medicine, claiming that around 10% of all clinical encounters were
for such conditions. He argued that the cures of modern medicine were
often worse than the disease – if indeed there was a disease in the ﬁrst
place, as Illich also attacked the medicalisation of everyday life, antic-
ipating the burgeoning of risk-deﬁned conditions that emerged in the
last quarter of the twentieth century.7
Thrush, the most prevalent opportunistic mycosis of the twentieth
century, exempliﬁes these trends. In the 1940s and 1950s, the emer-
gence of resistant bacteria was only one side effect of the new drugs.
More important then was the development of so-called ‘superinfec-
tions’, also caused by antibiotics as they removed not just disease-
causing bacteria but many others, and altered the normal microbial ﬂora
of the body. These changes opened the body to opportunistic infection
by other bacteria, such as Staphylococcus aureus, and by fungi, especially
Candida. This fungus had previously only affected the ‘external’ mucus
membranes in the mouth and genitalia, but emerged in the 1950s as a
rare, but serious, internal and systemic infection, where fungi grew on
major organs, such as the heart. It was not just patients on antibiotics
who were vulnerable. There were a growing number of patients whose
immune systems were weakened or immunocompromised. Initially, this
situation developed as a side effect of steroids and other similar treat-
ments, but then such states were deliberately produced by doctors to
aid the acceptance of transplanted organs, or as a by-product of new
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cancer therapies. In 1987, John W. Rippon, a leading American medical
mycologist, reﬂected on the situation.
The mycology of human infections in the 1980s is the mycology of
the soil, rotting vegetables, shower curtains, toilet bowls, leaf piles,
wilted ﬂowers and dung heaps. Organisms literally come out of the
walls to infect immunosuppressed patients. Technical medical and
surgical expertise is such that we can pass around hearts, lungs, and
livers only to be thwarted by a Fusarium from a rotting plum.8
Rippon was pointing to a larger truth about human fungal infections,
namely, that their prevalence has been linked to speciﬁc ecological con-
ditions and interactions, not only within the body, but also within the
wider social and physical environment. At the time Rippon wrote, the
United States, and soon the Western world, was gripped by a popular
health panic about fungal disease. Some fringe doctors promoted the
view that Candida infection was responsible for all manner of ‘modern’
ailments, including chronic fatigue syndrome (CFS) and inﬂammatory
bowel disease (IBD), in what they styled as ‘the yeast connection’.9
In this book, we discuss the changing medical and public proﬁle
of fungal infections in the period 1850–2000. We consider four sets
of diseases: ringworm and athlete’s foot (dermatophytosis); thrush or
candidiasis (infection with Candida albicans); endemic, geographically
speciﬁc infections in North America (coccidioidomycosis, blastomycosis
and histoplasmosis) and mycotoxins; and aspergillosis (infection with
Aspergillus fumigatus). We discuss each disease in relation to developing
medical knowledge and practices, and to social changes associated with
‘modernity’. Thus, mass schooling provided ideal conditions for the
spread of ringworm of the scalp in children, and the rise of college sports
and improvement of personal hygiene led to the spread of athlete’s foot.
Antibiotics seemed to open the body to more serious Candida infections,
as did new methods to treat cancers and the development of transplan-
tation. Regional fungal infections in North America came to the fore
due to the economic development of certain regions, where popula-
tion movement brought in non-immune groups who were vulnerable to
endemic mycoses. Fungal toxins or mycotoxins were discovered as by-
products of modern food storage and distribution technologies. Lastly,
the rapid development and deployment of new medical technologies,
such as intensive care and immunosuppression in the last quarter of
the twentieth century, increased the incidence of aspergillosis and other
systemic mycoses.
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In understanding and managing infectious diseases, scientists and
doctors have long argued for thinking about them in terms of the
metaphor of ‘seed and soil’, where the ‘seed’ is the infectious organism
or pathogen: that is, virus, bacteria, fungi, protozoa (single cell) or meta-
zoan (multicellular); and the ‘soil’ is the human body and its environs.10
Thus, for someone with the common cold, the notion of ‘seed and soil’
ensures that we go beyond focusing only on infection by the virus (the
seed) and consider the sufferer (the soil). This means looking at the con-
ditions in which the person was exposed to the virus, the quantity and
quality of the virus reaching the body, the nature of the body’s speciﬁc
immune response and the overall health of the individual. We all know
that we do not ‘catch a cold’ every time we are exposed to the virus
and that some people suffer longer and more serious illness than oth-
ers do. Some variations are individual, but epidemiological studies have
always shown patterns of exposure, susceptibility, sickness and recovery
by age, gender, class, occupation, ethnicity and other socio-cultural vari-
ables. For example, in their history of pulmonary tuberculosis, René and
Jean Dubos systematically use the notion of ‘seed and soil’ to discuss the
disease at all levels, from biological factors inﬂuencing the susceptibility
of cells and tissues, through to the socio-economic and technological
variables that have shaped global trends in morbidity and mortality.11
In this book, we frame our history of fungal infections in terms of
‘seed and soil’; hence, our ‘seeds’ are speciﬁc fungal pathogens and we
interpret ‘soils’ widely to include the human body, social relations and
structures, and the medical, material and technological environment.
Fungi
Fungi and how they cause diseases are not well known, so it will be
useful here to give a brief introduction to the nature of the ‘seeds’ of
mycoses. Our account is part historical and part current.
Mycology is the branch of science that studies fungi and until the
1960s, it was a part of botany, at which time its subject matter was
moved to the animal kingdom. Since then, fungi have been placed in
their own kingdom, with the other four being plants, animals, proto-
zoa and monera (bacteria).12 Current estimates are that there are well
over 100,000 species of fungi and many more are still to be classiﬁed,
let alone discovered. Some fungi are large and multicellular, like toad-
stools. However, most species are microscopic, single cell organisms and
are best known as industrial agents (yeast fungi in the production of
bread and beer) and as medical agents (Penicillia spp. remain the source
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of the world’s mostly widely used antibiotic). The larger fungi develop as
microscopic ﬁlaments called hyphae, which branch and grow into net-
works or colonies called mycelia, whereas smaller fungi, such as yeasts,
are single cell microorganisms.
Many writers divide fungi into ‘good’ and ‘bad’, judged by their
impact on human existence; fungi themselves, of course, are just ﬁll-
ing niches that allow them to multiply and survive. In popular writing,
the ‘good’ fungi are those used in industrial processes or medicine, such
as yeasts and penicillins mentioned above, plus those that can be eaten,
break down waste or work in plant roots to ﬁx nitrogen. The ‘bad’ fungi
are those that produce diseases in plants, animals and humans. In terms
of impact on humanity, fungi do most harm as causes of crop diseases
and amongst farm animals, but they are also a threat to homes, where
their ability to breakdown organic matter is seen most strikingly in the
dry rot fungus which can destroy wooden structures very rapidly. Most
fungi are saprophytic, that is, they obtain their nutrients from breaking
down organic matter, normally dead tissues, and absorbing the products
to ‘feed’ their metabolism. They mostly live on or within the material on
which they are feeding. A small number of fungi, and of course the ones
that concern medical mycologists, derive their nutrients from infecting
living tissue, either by destroying it, or through establishing a symbiotic
relationship that affects human tissues and their functioning.
Following long-established Linnaean principles, the classiﬁcation of
fungi was mainly by their reproductive and sexual characteristics. Thus,
the 1911 Encyclopaedia Britannica divided fungi into three groups: the
Basidiomycota, which produce club-like fruit bodies that spread spores
(e.g. mushrooms); the Ascomycota, which produce fruit bodies on special
pods or sac structures (e.g. baker’s yeast, penicillin and most human fun-
gal pathogens); and the Phycomycetes that reproduce sexually by spores
joining (e.g. black bread mould). These classiﬁcations held for most of
the twentieth century, though with many reﬁnements and revisions
with individual groups, genera and species. Certain fungi proved very
difﬁcult to classify as they had different forms in different stages of their
life cycle. In the ﬁnal decades of the century, the whole basis of ordering
fungi changed as the new types of analysis of their DNA (their genome
or genotype) revealed different relationships from those of their form
and function (phenotype). The ﬂuidity of understanding of the nature
and classiﬁcations of fungi was evident with the microorganism known
currently as Pneumocystis jiroveci. Through the 1980s, this organism was
regarded as a protozoan and named Pneumocystis carinii, when it was
the subject of extensive research as it was a major cause of pneumonia
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and death in HIV/AIDS sufferers.13 Indeed, Pneumocystis carinii pneumo-
nia (PCP) was an early marker of the epidemic and allegedly responsible
for the deaths of celebrities such as Freddie Mercury. The redesignation
of the organism as a fungus was ﬁrst made in 1988, based on work
using the new techniques of DNA sequencing, though this remained
controversial until the late 1990s when the reclassiﬁcation was ﬁnally
accepted.14
Fungal diseases
Geoffrey Ainsworth, who has written most extensively on the history
of fungal diseases, argues that fungi are amongst the oldest recog-
nised causes of infection in humans.15 Hippocrates seemingly wrote
on ‘aphthae’ (sores in the mouth) in 500 BC, which modern mycolo-
gists have identiﬁed as thrush. Two millennia later, ringworm infection
was present on the skin and in the hair of the subjects of Old Masters’
paintings. In the modern medical era, the ﬁrst systematic writings on
fungi as a source of human disease were by the Hungarian born, Paris-
based physician and microscopist David Gruby in 1842–1844. At the
time, fungi were understood to be the sources of a number of dis-
eases and attracted considerable scientiﬁc interest. In the 1830s, the
Italian entomologist Agostino Bassi published claims that the devastat-
ing muscardine disease of silkworms was due to a microscopic fungus
Tritirachium shiotae, which was eventually renamed in his honour as
Beauveria bassiana.16 Bassi was a major inﬂuence on Louis Pasteur, both
in his work on the silkworm diseases of pébrine and ﬂacherie in the
1860s and on the idea that living microorganisms might cause infectious
diseases. The work of Bassi and Pasteur showed that fungal infections
were, and in fact still are, the cause of economic problems in agri-
culture and related industries.17 Ainsworth goes on to make the point
that most ‘mycologists’ in Britain and the United States work as plant
pathologists, with a disciplinary allegiance to botany, and that medi-
cal mycologists were and remain quite a small minority, with a quite
different orientation.
In medicine in the 1830s, and in keeping with the then fashion-
able focus on pathological anatomy and lesions, distinctive and speciﬁc
fungal infections of the skin, such as favus and ringworm, were well
recognised. Classiﬁcations or nosologies of skin diseases were produced
in the early nineteenth century, most inﬂuentially in Thomas Bateman’s
A Practical Synopsis of Cutaneous Diseases According to the Arrangement
of Dr Willan (1813) and an atlas The Delineations of Cutaneous Disease
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in 1817.18 Many authors followed the French physician Jean Louis
Alibert in using extensive colour illustrations and some copied the wax
models (les moulages) that he collected at the Hôpital Saint-Louis in
Paris.19 The use of colour illustrations continued with photography,
as in Charles-Philippe Lallier’s Leçons cliniques sur les teignes, published
in 1878.20
The contagious and infectious aspects of fungal disease meant
that, from the 1860s, doctors and scientists regarded them as ‘germ
diseases’.21 Early historians of germ theories of disease certainly traced
the familiar lineage from van Leeuwenhoek through Bassi to Pasteur,
and the natural philosophers and medical men who used microscopy
and culturing to study fungi. David Gruby ﬁrst linked speciﬁc fungi to
favus, sycosis and ringworm infections of the human scalp in the 1840s.
For the latter, he ﬁrst described the clinical condition of tinea tonsurans
(scalp ringworm), though the terms ‘herpes tonsurans’ and ‘teigne
tondante’ also enjoyed currency.22 In the 1850s, botanists and dermatol-
ogists agreed on Trichophyton – literally hair-fungus due to its shape seen
through microscopes – as the main ringworm germ and, in line with
the wider switch to naming diseases by their causes rather than their
signs and symptoms, in France tinea tonsurans became ‘trichophytie’.
As we discuss in Chapter 1, these developments were followed by lead-
ing dermatologists, such as William Tilbury Fox and Thomas M’Call
Anderson, but most doctors and dermatologists remained focused on
morbid anatomy and nosologies based on signs and lesions.
Fungus theories of infectious disease were popular in the 1840s and
the best known was the ‘cholera fungus’.23 In a paper read to the
Microscopical Committee of the Bristol Literary and Philosophical Insti-
tution in 1849, ‘fungoid’ bodies were reported in the faeces of cholera
sufferers.24 The authors emphasised analogies between the growth and
decay of fungi, and the rise and fall of zymotic diseases in individuals
and in populations over epidemic periods. However, given that con-
temporaries thought that fungi were the ‘appointed executioners and
nimble scavengers of nature’, any such organisms were understood by
contemporary doctors to be the consequences rather than the causes of
cholera. Medical views on the causal role of living organisms in disease
waxed and waned from the 1840s to the 1880s, until bacterial germs
were accepted as major pathogens.25 At this time, bacteria were termed
as the ‘Schizomycetes’, literally the splitting fungi, so named because
they reproduced by the division of cells, and were believed to be a type
of fungi because of their microscopic form and physiological function
as saprophytes.
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One of the ﬁrst British textbooks on the new science of germs was
German Sims Woodhead and Arthur Hare’s Pathological Mycology pub-
lished in 1885.26 However, this was the only time ‘mycology’ was used
in this context; the German term Bacteriologie soon took over. In the
new manuals and textbooks on ‘bacteriology’ and ‘microbiology’, fungi
as causes of infection were, at best, described brieﬂy and typically in
a ﬁnal chapter or appendix. For example, Muir’s and Ritchie’s inﬂuen-
tial Manual of Bacteriology, published in 1899, had a chapter entitled
‘Non-Pathogenic Micro-organisms – Fungi’, and presented them as likely
laboratory contaminants rather than pathogens. The authors discussed
Mucor spp., Oidium spp., Aspergillus niger, Penicillium glaucum, plus yeasts,
and ended with the comment, ‘Certain fungi closely related to the above
are pathogenic agents.’ Readers were referred to Anton De Bary’s Com-
parative Morphology and Biology of the Fungi, Mycetozoa and Bacteria, ﬁrst
published in 1886, for further details.27
In the twentieth century, fungi were recognised as causing three types
of disease in humans and animals. First, there were infections where
fungi develop parasitically in the tissues of the host, at (literally) three
levels: superﬁcial mycoses, like athlete’s foot, where infection is lim-
ited to the outermost layers of the skin, nails and hair; subcutaneous
mycoses, like the tropical disease of Madura foot (mycetoma), where
the growth extends to the underlying layers of the skin and perhaps into
bone; and systemic mycoses, like aspergillosis, where infection spreads
through internal organs and tissues.
Second, there were fungal poisons, either toxins in the fungi them-
selves, as with poisonous toadstools, or toxins produced by the growth
of fungi on foodstuffs, as with aﬂatoxins (produced by Aspergillus ﬂavus).
Third, there were allergic reactions to fungal spores and moulds, which
range from mild to acute, depending on the dose and susceptibility of
the host; thus, fungi are a common cause of asthma. There was a fourth
type of disease that was ‘discovered’ in the 1980s and remains highly
contested – ‘fungal overgrowth’. As we show in Chapter 3, this condi-
tion has been widely dismissed by the medical profession as a ﬁction,
yet it had wide currency with the public and was linked to CFS and
other ‘diseases of modernity’. In the cultural climate in North America
and Europe, where lifestyle was increasingly regarded as a cause, as well
as a solution, to ill health, books such as William G. Crook’s The Yeast
Connection (1983), which attributed various chronic conditions to the
overgrowth of C. albicans, became a best seller and spawned many imi-
tators. Crook also had the cure: dietary and lifestyle changes, plus a
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course of antifungal antibiotics, which was surprising given his pedigree
in ‘alternative medicine’.
The history of medical mycology
The multi-faceted career of medical mycology’s leading historian Geof-
frey Ainsworth exempliﬁes the diverse and changing character of the
ﬁeld in the twentieth century. He studied pharmacy at University Col-
lege, Nottingham, and then pursued a dual career in plant pathology
and medical mycology.28 He ﬁrst worked on the virus diseases of plants
at Britain’s two leading botanical institutions, the Rothamsted Experi-
mental Station and the Experimental and Research Station in Cheshunt.
He spent the Second World War at the Imperial Mycological Insti-
tute at Kew, developing abstracting services on all aspects of mycology.
After the war, he moved to the pharmaceutical industry, as head of
the mycological department of the Wellcome Research Laboratories at
Beckenham, Kent. There he led work on the antibiotics produced by
fungi, such as streptomycin and penicillin. He then moved, ﬁrst, to the
London School of Hygiene and Tropical Medicine and later to the Uni-
versity of the South West (later the University of Exeter), before return-
ing to the now Commonwealth Mycological Institute, where he stayed
until his retirement in 1968. Ainsworth published widely on all aspects
of fungi. His major works were Dictionary of the Fungi (1943), British
Smut Fungi (1950) with Kathleen Sampson, Medical Mycology (1952),
and the multi-volume The Fungi: An Advanced Treatise (1965–1973) with
A. S. Sussman and F. K. Sparrow.
Towards the end of his career, Ainsworth developed an interest in
the history of mycology and published three books that have been
immensely valuable in the research and writing of this book: Introduc-
tion to the History of Mycology (1976), Introduction to the History of Plant
Pathology (1981) and Introduction to the History of Medical and Veterinary
Mycology (1987).29 In his preface to the latter volume, he sets out his
approach and the scope of the topic.
Although possessing deep, if slender roots that can be traced back
to ancient times, medical and veterinary mycology is essentially a
development of the twentieth century, especially the last ﬁfty years
during which time several mycoses at ﬁrst considered to be rarities
have been shown to affect millions of men, women, and children and
their domesticated animals . . . . Here the attempt made to sketch in
10 Fungal Disease in Britain and the United States 1850–2000
the historical background, by illustrating the approaches to a series of
basic problems, is limited to what might be described as the ‘natural
history’ of human and animal mycoses.30
While we agree with Ainsworth on the point that the development of
medical mycology was a phenomenon of the twentieth century, our
work differs in two ways. First, we do not take the specialism of medical
mycology as given, or historically constant, rather as a social institution
that had to be created and sustained. Second, we do not set out a lineage
of ideas, but rather discuss changing knowledges in speciﬁc institutional
and social settings, and also explore practices and meanings.31
The history of medical mycology in the United States in the twen-
tieth century has been described in great detail in a monograph by
Ana Victoria Espinel-Ingroff published in 2006.32 Her narrative is com-
prehensive and wonderfully rich in characters and institutional detail.
It focuses on training and mapping the professional networks that have
shaped medical mycology across the country. At the same time, the
author tells the story of discoveries in the understanding and manage-
ment of the main fungal infections that affect Americans. It is history
informed by disciplinary politics, as Espinel-Ingroff’s reference point is
what she sees as a crisis in medical mycology in the United States. On the
one hand, the importance of mycoses has grown with their increased
prevalence and the arrival of effective antifungal drugs. Yet, on the other
hand, the ﬁeld seems to be fragmenting, being drawn at one end to
molecular approaches and basic biology, and at the other to applied
clinical research, leading to the neglect of the old, middle ground of
taxonomy, aetiology, physiology and pathogenesis.
Woven into Espinel-Ingroff’s history narrative is a narrative of devel-
opments in the ﬁeld in the twentieth century, with ﬁve periods deﬁning
her chapters. The discussion of the ‘Era of Discovery (1894–1919)’
explores how work on fungi followed that in bacteriology in seeking the
causal organisms of speciﬁc infections and the understanding of basic
fungal biology. The ‘Formative Years (1920–1949)’ are characterised by
the establishment of training programmes, laboratory services and epi-
demiological studies of common diseases, such as athlete’s foot and
thrush, or the then very rare systemic mycoses. The period 1950–1969,
the ‘Advent of Antifungal and Immunosuppressive Therapies’, was dom-
inated by drug discoveries (nystatin, amphotericin B, griseofulvin) and
the increased incidence of severe opportunistic systemic fungal infec-
tions that were linked to antibiotics and immunosuppressive therapies.
The ‘Years of Expansion (1970–1979)’ are portrayed as the apogee of
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medical mycology, seen in the establishment of services to deal with
the increased incidence of infections, basic research to underpin clinical
innovations and the recognition of the specialty by the American Soci-
ety for Microbiology (ASM). Finally, the ‘Era of Transition (1980–1996)’
saw continued increase in the incidence of opportunistic infections in
cancer and transplant patients, and amongst AIDS patients, but also the
fragmentation and relative neglect of the specialism.
What few histories there are of fungal infections are largely embedded
in accounts of the development of the specialty of medical mycology,
but there are a number of books and journal articles on speciﬁc infec-
tions. There is only one monograph on a disease discussed in this book,
Thomas Daniel and Gerald L. Baum’s Drama and Discovery: The Story of
Histoplasmosis.33 Their narrative follows the emergence of the disease
from social changes in its endemic areas and the research networks in
which new understandings of its epidemiology, aetiology, pathology
and treatment developed. It is typical of much work on the history
of mycoses, as with Ainsworth and Espinel-Ingroff, in being written
by medical mycologists, but is quite different and richer as it explores
the social as well as medical history of histoplasmosis.34 There are no
book length histories of coccidioidomycosis and blastomycosis com-
parable to Drama and Discovery, but there are very useful practitioner
histories, for example, Jan Hirschmann’s account of the early history of
coccidioidomycosis in America.35
Yet, as we have indicated, ‘biographies’ of mycoses written by med-
ical historians are rare. Aspergillosis has no thoroughgoing histories.36
Ringworm has few historians in Britain and the United States, and even
reﬂections by practitioners are rare.37 It has only excited attention in
Israel, in relation to the controversy of the long-term effects on chil-
dren of X-ray treatment of the scalp and popular representations of the
practice as the ‘Ringworm Holocaust’.38 It is also surprising that histori-
ans of medicine in the United States, who have thoroughly investigated
popular medications and health activism, have missed athlete’s foot, a
condition that plagued not only the athletes but the country’s youth,
soldiers and miners.
Mycoses and medical history
In this book, we aim to do more than provide a narrative of a group
of neglected infections. Our study also gives new perspectives on the
history of twentieth-century medicine on a number of fronts: speciali-
sation; minor illnesses and self-treatment; and ‘orphan diseases’. Firstly,
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we present an account of an area of medicine – medical mycology –
that for most of the twentieth century was small and marginal, and
where practitioners struggled to establish an area of specialist work. The
development of specialisms and specialisation has long interested his-
torians of medicine.39 George Rosen’s study of ophthalmology was path
breaking and work since then has linked the division of labour to many
factors within medicine and outside. George Weisz, in the most recent
and comprehensive study on the topic, ﬁnds that ‘divide and conquer’
best explains the overall process in medicine, as these terms ‘[express] a
fundamental intellectual strategy’, whereby medical professionals were,
in a matter of a century, divided into ‘smaller and more manageable
groups based on common attributes’ and conquered by ‘organization
based on a novel kind of expertise’.40
Most histories of specialisation and specialisms are of successful enter-
prises and can be teleological, charting the seemingly inevitable journey
to the present division of labour in medicine. Our narrative of medical
mycology runs against this grain, though it does not present medical
mycology as a failed specialism, rather one, as Espinel-Ingroff’s work
makes clear, the position and status of which was always problematic.
For most of the twentieth century, it was small, institutionally frag-
mented and dispersed geographically. Its practitioners tried to ‘divide’
themselves off from other specialisms but were relatively unsuccess-
ful because their services were never in sufﬁcient demand to form
a critical mass either numerically or politically. Thus, we challenge
the accepted, though often implicit, view that specialisation was an
inevitable path in twentieth-century medicine, where it becomes ever
more populated with full-time ‘mono-specialists’; that is, clinicians
and scientists who worked on a single disease or group of diseases, a
particular organ or organ system, speciﬁc technologies or a restricted
patient group, say, by age or sex. Our research on the doctors and
researchers who treated and studied fungal infections shows a differ-
ent, and perhaps equally common, pattern of work: clinicians and
scientists making a living as working in and combining a number of
specialisms.41
We suggest that it is useful to think about twentieth-century medicine
generally in terms of the doctors, and other health workers for that
matter, developing careers in a number of ‘specialist practices’. His-
torians of medicine often overlook the fact that doctors and medical
scientists had to ‘make a living’, and that in less wealthy times, when
health was a lower priority in private and state budgets, this was done
by earning where they could and what they could.42 In this con-
text, ‘medical mycology’ was an area of ‘specialist practice’ for certain
Introduction 13
botanists, dermatologists, bacteriologists, hospital physicians and sur-
geons, infectious disease doctors, microbiologists, general practitioners
or, of course, combinations of these. Typically, ‘specialist practice’ was
in cognate areas; hence, the ﬁrst ‘medical mycologists’ were mostly
botanists, or those who created the specialism of dermatology. Never-
theless, in the late nineteenth century few doctors were able to work
full-time on skin diseases, so dermatologists were often general practi-
tioners, who functioned as part-time specialists, part-time in hospital
outpatient clinics.
Secondly, and as noted already, fungal infections represent the over-
whelming experience of illness, then and now, like the common
colds, sickness and diarrhoea, and sore throats that are self-limiting,
self-treated or treated after one short consultation with a general
practitioner.43 Research in the 1980s revealed that on average only one
in 20 ‘symptom episodes’ led to a medical consultation, a pattern that
was termed the ‘iceberg of illness’.44 If that was the position in a country
with a National Health Service, offering care that was ‘free at the point
of delivery’, the proportion would almost certainly be lower in pay-for-
service medical and healthcare systems, then and now. There are few
studies, except for the era of ‘bedside medicine’, of the everyday expe-
rience of illness, and of decisions on when and how to self-treat, and
when and how to seek medical consultation and become a patient.45
That said, our focus is on the medical history of mycoses – a suf-
ferer’s history would be quite different and, in fact, very difﬁcult to
research. However, we do try to capture sufferers’ agency, for example, in
our discussion of the proliferation of proprietary remedies for athlete’s
foot and thrush.
Thirdly, and at the other end of the scale of prevalence, systemic fun-
gal infections have been classiﬁed as ‘orphan diseases’; that is, those too
rare to attract the attention of research agencies or the interest of many
clinicians and researchers.46 The term originated in the United States
and the Orphan Drug Act, 1983, promoted by the National Organization
for Rare Disorders and the Federal Drugs Agency (FDA). In the United
States ‘orphan diseases’ are those with a prevalence of less than 2,000
cases per year. By the end of the twentieth century, the rise in the inci-
dence of mycoses meant that this designation only applied to the geo-
graphically localised infections and the rarer types of hospital acquired
or nosocomial infections. Yet, for most of the twentieth century, oppor-
tunistic, invasive mycoses were rare and medical mycologists and other
interested parties bemoaned their neglect. In part, this was because such
infections were seen as ‘diseases of the diseased’ and affected patients
who were seriously ill and close to death. In fact, doctors spoke of these
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patients receiving ‘salvage therapies’, where ethical standards were dif-
ferent and there was scope of experiment and the non-standard use of
standard drugs. Interestingly, when invasive mycoses ceased to be ‘rare’,
they attracted the attention of many surgical and medical specialists,
and researchers in pharmaceutical companies, who sought to transfer
their successes with mass market, external antifungals to invasive, sys-
temic disease. Indeed, the story of medical mycology in the second half
of the twentieth century is dominated by the development of new anti-
fungal antibiotics, principally polyenes (e.g. nystatin and amphotericin
B), azoles (e.g. clotrimazole and ketoconazole), triazoles (e.g. ﬂuconazole
and itraconazole) and echinocandins (e.g. caspofungin), targeted at the
‘seeds’ of infection.
The book
We discuss our four sets of infection in ﬁve chapters: two on ringworm
(dermatophytosis), and one each on thrush, the geographically spe-
ciﬁc mycoses and mycotoxins, and aspergillosis. We present histories
of each disease group and while our approach is essentially thematic,
there is an overall movement through time. Thus, the ﬁrst chapter
on ringworm begins in the mid-nineteenth century and ends around
1910, while the ﬁnal chapter on aspergillosis is mainly about changes in
the last quarter of the twentieth century. Our narrative moves between
Britain and the United States following the changing locations where
medical and social interest and activity was greatest. We are neither
comprehensive nor comparative in our discussion of medical mycol-
ogy in these two national contexts. However, we use the fact that work
on fungal infections in the twentieth century, as demonstrated by the
work of the International Society for Human and Animal Mycology
(ISHAM), was dominated by an Anglo-American axis, though this is not
to diminish in any way activities in other countries, which we discuss as
appropriate.
Our ﬁrst chapter frames ringworm as a disease of schools and
schoolchildren. The disease had been reported previously in orphan-
ages and similar institutions, but its incidence and proﬁle increased with
the arrival of mass schooling, which provided ideal conditions for its
spread, both through increased opportunities for contagion (seeding)
and the exposure of poor children (weakened soil). We look at responses
to the problem, one of which was special schools for the isolation and
treatment of sufferers, and which became sites for the use of the new
X-ray technologies, not to kill the seeds of infection, but to alter the
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soil by removing hair, the locus of infection. In the second chapter, we
move from head to toe, from Britain to the United States, and focus on
athlete’s foot. Concern over ringworm infection of the feet, along with
infection of the crotch, armpit and similar areas of the body, began in
the 1920s, principally amongst sportsmen and women. Athlete’s foot
was described as a perverse consequence of the nation’s attempt to
improve the health and ﬁtness of its youth, especially with the bur-
geoning of college sports and improved hygiene facilities. The infection
was met with the tools of modern public health propaganda, being pre-
sented in some instances as equivalent to a sexually transmitted disease,
and by new methods of treatment produced by the pharmaceutical
industry, ﬁrst in a rash of proprietary medicines and then antifungal
antibiotics.
Thrush, the subject of our third chapter, was regarded at the start of
the twentieth century as a disease of weak children, but moved in the
medical and public view to a genital infection, principally of women
and was linked mainly to alterations in the body due to pregnancy
and lifestyle changes.47 We then discuss how, in the second half of the
twentieth century, thrush was linked in different ways to the develop-
ment of antibiotics. It was soon recognised as a side effect of penicillin
therapy, while the search for new and better bacterial antibiotics led
to the discovery of nystatin – the ﬁrst modern antifungal antibiotic,
which soon became a speciﬁc treatment for thrush. Systemic C. albi-
cans infection, known as invasive candidiasis, became, paradoxically,
more prevalent in patients taking bacterial antibiotics, but also in those
with cancers, transplants and inﬂammatory conditions. This problem
was met by a search for new antifungal drugs, with successes improving
the institutional position of medical mycology. We end the chapter with
a discussion of ‘The Yeast Connection’ phenomenon.
In Chapter 4, we discuss the regionally speciﬁc fungal infections in
the United States that came to the fore as a consequence of the eco-
nomic development of certain regions in the South and Midwest, where
population movement brought in non-immune groups who were vul-
nerable to endemic mycoses. The forms of economic development were
also important, as new methods of production and types of industrial
and domestic construction created new environmental conditions, and
in some cases literally transformed and transported fungi-laden soil
dust. In the same vein, we show how new technologies of food pro-
duction, transportation and storage produced a new class of hazardous
compounds – mycotoxins. In our ﬁnal chapter, we discuss aspergillo-
sis, the most serious of the invasive mycoses that have emerged from
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new medical technologies, such as intensive care and immunosuppres-
sion. An important theme here is iatrogenesis, as attempts to control
aspergillosis exempliﬁed the now routine issue in modern medicine of
balancing the beneﬁts and adverse effects of primary treatment, with
secondary and tertiary interventions.
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